Settings
BIOD [NASD]
Biodel Inc.
Index- P/E- EPS (ttm)-0.66 Insider Own10.21% Shs Outstand23.42M Perf Week3.42%
Market Cap35.36M Forward P/E- EPS next Y-1.35 Insider Trans0.00% Shs Float23.27M Perf Month10.22%
Income-14.10M PEG- EPS next Q-0.17 Inst Own32.00% Short Float3.01% Perf Quarter-0.66%
Sales- P/S- EPS this Y46.80% Inst Trans27.62% Short Ratio2.76 Perf Half Y-20.53%
Book/sh1.02 P/B1.48 EPS next Y-43.60% ROA-55.70% Target Price5.67 Perf Year-44.07%
Cash/sh1.05 P/C1.44 EPS next 5Y- ROE-66.60% 52W Range1.20 - 3.71 Perf YTD13.53%
Dividend- P/FCF- EPS past 5Y18.40% ROI- 52W High-59.30% Beta2.06
Dividend %- Quick Ratio15.60 Sales past 5Y- Gross Margin- 52W Low25.83% ATR0.09
Employees30 Current Ratio15.60 Sales Q/Q- Oper. Margin- RSI (14)53.34 Volatility4.71% 6.49%
OptionableYes Debt/Eq0.00 EPS Q/Q-150.00% Profit Margin- Rel Volume0.56 Prev Close1.53
ShortableYes LT Debt/Eq0.00 EarningsFeb 04 AMC Payout- Avg Volume253.76K Price1.51
Recom1.80 SMA202.20% SMA503.78% SMA200-17.03% Volume141,930 Change-1.31%
May-10-13Upgrade Ladenburg Thalmann Neutral → Buy $6
Apr-16-12Upgrade JMP Securities Mkt Perform → Mkt Outperform $3
May-26-11Initiated Global Hunter Securities Accumulate $5
Feb-04-11Reiterated Wedbush Outperform $7 → $5
Dec-10-10Reiterated Wedbush Outperform $10 → $7
Nov-02-10Reiterated Wedbush Outperform $17 → $10
Nov-02-10Downgrade Ladenburg Thalmann Buy → Neutral $14 → $2
Oct-19-10Initiated JMP Securities Mkt Perform
Mar-25-09Reiterated Wedbush Morgan Buy $10 → $16
Mar-25-09Reiterated Ladenburg Thalmann Buy $9.50 → $14
Dec-11-08Reiterated Ladenburg Thalmann Buy $11 → $9.50
Nov-20-08Reiterated Cantor Fitzgerald Buy $33 → $15
Sep-19-08Downgrade Argus Buy → Sell
Sep-11-08Initiated Oppenheimer Perform
Sep-08-08Reiterated Ladenburg Thalmann Buy $23 → $11
May-16-08Initiated Cantor Fitzgerald Buy $33
May-02-08Initiated Pacific Growth Equities Buy
Feb-27-08Initiated JP Morgan Overweight
Feb-25-08Initiated Punk, Ziegel & Co Buy $23
Jun-20-07Initiated Banc of America Sec Buy $23
Jan-29-15 05:30PM  Galmed, Perrigo Tie Up for Mass Production of Aramchol API - Analyst Blog Zacks
04:30PM  Will Generics Continue to Hit Eli Lilly's (LLY) Q4 Earnings? - Analyst Blog Zacks
Jan-28-15 06:30PM  Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog Zacks
Jan-27-15 05:38PM  NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst Blog Zacks
05:15PM  Will AmerisourceBergen (ABC) Earnings Surprise in Q1? - Analyst Blog Zacks
Jan-26-15 05:20PM  Shire's Elvanse Gets Positive Response for ADHD in Adults - Analyst Blog Zacks +5.48%
Jan-23-15 05:50PM  Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog Zacks +5.80%
Jan-22-15 07:00PM  UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog Zacks
Jan-21-15 05:35PM  Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog Zacks
04:15PM  CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst Blog Zacks
04:05PM  Immunomedics Reports Data on Oncology Candidate - Analyst Blog Zacks
02:00PM  ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog Zacks
Jan-20-15 02:10PM  Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Zacks
Jan-19-15 02:10PM  UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog Zacks
Jan-15-15 04:30PM  Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog Zacks
02:30PM  Regado Biosciences to Merge with Tobira Therapeutics - Analyst Blog Zacks
Jan-07-15 05:49PM  Wednesday's After-Hours Movers Benzinga
04:23PM  BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:00PM  Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Post-Meal Glucose Control Compared to Marketed Prandial/Basal Insulins in Patients With Diabetes Who Require High Doses of Insulin Marketwired
Dec-30-14 01:04PM  BIODEL INC Financials EDGAR Online Financials
Dec-21-14 07:07PM  10-K for Biodel, Inc. Company Spotlight
Dec-19-14 04:03PM  BIODEL INC Files SEC form 10-K, Annual Report EDGAR Online
Dec-17-14 04:31PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:00PM  Biodel Reports Fourth Quarter Fiscal Year 2014 Financial Results Marketwired
07:07AM  Q4 2014 Biodel Inc Earnings Release - 4:00 pm ET CCBN
Dec-10-14 04:20PM  Roche (RHHBY) Presents Positive Data on Haemophilia Drug Zacks
04:00PM  Biodel to Report Fourth Quarter Fiscal Year 2014 Financial Results on December 17, 2014 Marketwired
Dec-09-14 07:00AM  Cempra (CEMP) in Focus: Stock Rises 11.4% in Session Zacks
05:52AM  Tetraphase Pharmaceuticals (TTPH) Jumps: Stock Up 8.8% Zacks
Dec-04-14 04:19PM  Biodel Initiates Clinical Proof of Concept Study in Glucagon Emergency Management Program Marketwired -5.41%
Nov-18-14 04:02PM  Biodel Successfully Defends Ultra-Rapid-Acting Insulin Formulation Technology in European Patent Office Opposition Proceedings Marketwired
06:17AM  ArQule (ARQL) Shows Strength: Stock Adds 6 % in Session Zacks
06:13AM  Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 6.4% Zacks
Nov-07-14 05:46AM  Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% Zacks
Nov-03-14 05:47AM  Flamel Technologies (FLML) Crumbles: Stock Falls by 7.1% Zacks
Oct-30-14 07:24AM  Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% Zacks
Oct-27-14 09:37AM  BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Sep-15-14 07:00AM  Biodel Announces Data Presentations at the 50th Annual Meeting of the EASD Marketwired
Aug-27-14 04:00PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Aug-25-14 04:00PM  Biodel Appoints Gary G. Gemignani as Chief Financial Officer Marketwired
Aug-14-14 09:58AM  Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update Zacks
Aug-13-14 05:01PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-11-14 05:02PM  [video] Stocks Close Higher, But Off Day's Highs at TheStreet
04:30PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Biodel Reports Third Quarter Fiscal Year 2014 Financial Results Marketwired
07:30AM  Biodel's insulin drug found effective in trial Reuters
07:07AM  Q3 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
07:00AM  Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Glucose Control Following Standardized Meals Compared to Marketed Insulins in a Phase 2 Clinical Trial in Patients With Type 2 Diabetes Marketwired
Aug-06-14 07:00AM  Biodel to Present at the Wedbush PacGrow Life Sciences Management Access Conference Marketwired
Aug-05-14 07:00AM  Biodel to Report Third Quarter Fiscal Year 2014 Financial Results on August 11, 2014 Marketwired
Jul-28-14 06:00AM  Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital Marketwired
Jun-11-14 07:30AM  Biodel to Present at the JMP Securities Healthcare Conference Marketwired
Jun-10-14 07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions Marketwired +5.41%
May-23-14 04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
May-16-14 09:20AM  Biodel Q2 Loss Wider Than Expected Zacks
May-14-14 05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
May-13-14 08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c) at theflyonthewall.com
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results GlobeNewswire
07:07AM  Q2 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
May-07-14 04:00PM  Biodel to Report Second Quarter Fiscal Year 2014 Financial Results on May 13, 2014 GlobeNewswire -5.33%
Apr-24-14 04:30PM  Biodel, HEC Pharm Ink Deal Zacks
Apr-22-14 04:02PM  Biodel announces insulin collaboration pact with HEC Pharm at theflyonthewall.com
04:00PM  Biodel Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation GlobeNewswire
Apr-16-14 12:30PM  Abbott Labs Tops Earnings, Misses Sales Est Zacks
Mar-10-14 04:06PM  BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Mar-05-14 07:04PM  On The Fly: After Hours Movers at theflyonthewall.com
04:00PM  Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product GlobeNewswire
Mar-04-14 07:00AM  Biodel to Present at the 26th Annual ROTH Conference GlobeNewswire
Feb-13-14 04:40PM  Positive Phase I Data from Biodel Zacks
Feb-12-14 04:30PM  Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results GlobeNewswire
Feb-10-14 04:33PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online +8.66%
01:49PM  Biodel Q1 Loss Narrows Zacks
Feb-07-14 11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
Feb-06-14 04:51PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:03PM  Biodel Reports First Quarter Fiscal Year 2014 Financial Results GlobeNewswire
11:40AM  Avanir Reports Narrower Loss, Revs Up Y/Y Zacks
07:07AM  Q1 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
Feb-05-14 04:00PM  Biodel to Report First Quarter Fiscal Year 2014 Financial Results on February 6, 2014 GlobeNewswire
Feb-04-14 04:15PM  Biodel to Present at Upcoming Conferences GlobeNewswire
Jan-08-14 09:28AM  Some Stock Ideas For January 2014 at Seeking Alpha
Jan-02-14 01:11PM  5 Stocks Under $10 Set to Soar at TheStreet +21.49%
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
Dec-27-13 11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets at TheStreet
Dec-20-13 04:03PM  BIODEL INC Files SEC form 10-K, Annual Report EDGAR Online
Dec-19-13 06:03PM  Nasdaq stocks posting largest volume increases AP
Dec-18-13 09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha -5.19%
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results GlobeNewswire
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q4 2013 BIODEL INC Earnings Release - 4:30 pm ET CCBN
Dec-17-13 08:17AM  Biodel Announces Commercial Supply Agreement With BD for Liquid Glucagon Rescue Device GlobeNewswire
Dec-12-13 07:00AM  Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013 GlobeNewswire
Nov-07-13 04:00PM  InPlay: Biodel advances ultra-rapid-acting concentrated insulin formulation into clinical development Briefing.com
04:00PM  Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development GlobeNewswire
Sep-24-13 09:55AM  Biodel CEO Buys 10K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
Sep-19-13 04:40PM  Is Biodel A Buy Or Sell? at Seeking Alpha
Sep-12-13 10:55AM  Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy at Seeking Alpha
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. Its lead product candidate is a glucagon emergency management (GEM) device that is intended to treat diabetes patients experiencing severe hypoglycemia, or very low concentrations of blood glucose. The company is conducting a Phase 1 clinical trial to assess the pharmacokinetic and pharmacodynamic profiles of BIOD-961, the reconstituted glucagon formulation intended for use in the GEM device. It also develops ultra-rapid-acting proprietary insulin formulations, such as BIOD-123, which has been evaluated in a Phase 2 clinical trial combining recombinant human insulin with its proprietary combination of excipients; and BIOD-531, a concentrated ultra-rapid-acting insulin formulation. The company was founded in 2003 and is headquartered in Danbury, Connecticut.